MDT-0123 Japan Study | MicrobiomeTrials← Back to trialsNCT07414745
MDT-0123 Japan Study
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-24Est. Completion: 2028-03-31
Enrollment target: 140 participants Locations- Kobe University Hospital, Kobe, Hyōgo, Japan
- Tokai University Hospital, Isehara, Kanagawa, Japan
- Wakakusa Daiichi Hospital, Higashiosaka, Osaka, Japan
- Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan
- Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan
- Sonoda Medical Corporations Sonoda Third Hospital, Adachi-Ku, Tokyo, Japan
- Toranomon Hospital, Minato-Ku, Tokyo, Japan
- Tokyo General Hospital, Nakano-Ku, Tokyo, Japan
- Shunyokai Medical Corporation Sangubashi Spine Surgery Hospital, Shibuya-Ku, Tokyo, Japan
- Keio University Hospital, Shinjuku-Ku, Tokyo, Japan
- Kyoto City Hospital, Kyoto, Japan
- Kitano Medical Research Institute Hospital, Osaka, Japan
- Osaka General Hospital of West Japan Railway Company, Osaka, Japan
- Japan Community Health care Organization Osaka Hospital, Osaka, Japan
Other microbiome trials you might be interested in
Degenerative Disc Disease LumbarSpondylolisthesis, Grade 1
The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo…
Charlotte, United StatesCompleted May 22, 2023
Degenerative Disc DiseaseSpondylolisthesisRetrolisthesis
The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo…
Lancaster, United StatesCompleted Jan 27, 2026
Recruiting
Cervical Disc Degeneration
Observational data collection of information after undergoing standard Cervical spine fusion surgery.
Halle, GermanyEst. completion Jun 2027